Advanced in Thyroid Dysgenesis

Elif Hindie

CHU De Bordeaux
Bordeaux, FR 
Advanced in Thyroid Dysgenesis
CHU De Bordeaux
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Elif Hindie practices in Bordeaux, France. Ms. Hindie is rated as an Advanced expert by MediFind in the treatment of Thyroid Dysgenesis. Her top areas of expertise are Breast Cancer, Hyperparathyroidism, Parathyroid Adenoma, Parathyroidectomy, and Thyroidectomy.

Her clinical research consists of co-authoring 188 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Thyroid Dysgenesis.

Gender
Female

Locations

CHU de Bordeaux
Bordeaux, 33000, France
Other Locations
Trail, Bordeaux, France
LabEx TRAIL, Pessac-sur-dordogne, 33604, France
CNRS UMR 5287, LabEx TRAIL, Pessac-sur-dordogne, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET ( Positron Emission Tomography) F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin
Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET ( Positron Emission Tomography) F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin
Enrollment Status: Completed
Publish Date: March 08, 2021
Intervention Type: Other
Study Phase: Not Applicable
A Randomized Phase III of Adjuvant Targeted Radionuclide Therapy With In111-Pentetreotide in Patients With Digestive Neuroendocrine Tumors After Complete Surgical Resection of Liver Metastases.
A Randomized Phase III of Adjuvant Targeted Radionuclide Therapy With In111-Pentetreotide in Patients With Digestive Neuroendocrine Tumors After Complete Surgical Resection of Liver Metastases.
Enrollment Status: Terminated
Publish Date: February 28, 2019
Intervention Type: Drug, Other
Study Phase: Phase 3
View 1 Less Clinical Trial

188 Total Publications

French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM.
French expert consensus statement on diagnosis and MANAGEMENT of PRIMARY HYPERPARATHYROIDISM.
Journal: Annales d'endocrinologie
Published: September 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Hindie's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile